During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...
"Part man. Part dog. All hero." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback